Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Generation of a new bioluminescent model for visualisation of mammary tumour development in transgenic mice

  • Agnieszka M Zagozdzon1,
  • Patrick O’Leary1,
  • John J Callanan2,
  • John Crown3,
  • William M Gallagher1Email author and
  • Radoslaw Zagozdzon1
BMC Cancer201212:209

DOI: 10.1186/1471-2407-12-209

Received: 14 December 2011

Accepted: 30 May 2012

Published: 30 May 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
14 Dec 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
15 Dec 2011 Author responded Author comments - Radoslaw Zagozdzon
Resubmission - Version 4
15 Dec 2011 Submitted Manuscript version 4
25 Jan 2012 Reviewed Reviewer Report - Jeffrey Segall
7 Feb 2012 Reviewed Reviewer Report - Ruth Keri
8 Mar 2012 Author responded Author comments - Radoslaw Zagozdzon
Resubmission - Version 5
8 Mar 2012 Submitted Manuscript version 5
20 Mar 2012 Reviewed Reviewer Report - Ruth Keri
26 Mar 2012 Reviewed Reviewer Report - Jeffrey Segall
19 Apr 2012 Author responded Author comments - Radoslaw Zagozdzon
Resubmission - Version 6
19 Apr 2012 Submitted Manuscript version 6
Publishing
30 May 2012 Editorially accepted
30 May 2012 Article published 10.1186/1471-2407-12-209

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Cancer Biology and Therapeutics Group, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin
(2)
UCD School of Veterinary Medicine & Conway Institute
(3)
Molecular Therapeutics for Cancer Ireland (MTCI), c/o National Institute for Cellular Biotechnology, Dublin City University

Advertisement